Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lhasa Men-Tsee-Khang, officially known as the Tibetan Medical Hospital of the Tibet Autonomous Region, is a premier institution dedicated to the practice, research, and production of Traditional Tibetan Medicine (TTM). Founded in 1916, it serves as a central hub for TTM, integrating clinical services with large-scale pharmaceutical manufacturing. The institute is famous for its "Precious Pills," which are complex pharmacological preparations used to treat a variety of chronic conditions, including stroke, gastrointestinal disorders, and liver diseases. Lhasa Men-Tsee-Khang operates state-of-the-art GMP-certified facilities to ensure the quality and safety of its traditional formulas. By bridging ancient healing traditions with modern medical standards, the organization plays a vital role in the healthcare landscape of the Tibet Autonomous Region and beyond. Its products are distributed widely across China and are increasingly recognized in the global alternative medicine market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lhasa Men-Tsee-Khang.